Who makes accupril, alpha lipoic acid?

accupril, alpha lipoic acid is developed by InVasc Therapeutics, Inc..

What development phase is accupril, alpha lipoic acid in?

accupril, alpha lipoic acid is in Phase 1.

Last reviewed 2026-04-20 · How we verify

accupril, alpha lipoic acid

InVasc Therapeutics, Inc. · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	accupril, alpha lipoic acid
Also known as	quinapril, accupril, ALA, alpha lipoic acid, lipoic acid
Sponsor	InVasc Therapeutics, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Effects of Quinapril 40 mg With Alpha Lipoic Acid or Placebo on Diabetes and Hypertension (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

accupril, alpha lipoic acid CI brief — competitive landscape report
accupril, alpha lipoic acid updates RSS · CI watch RSS
InVasc Therapeutics, Inc. portfolio CI